This article highlights RedShiftBio's MMS™ technology, detailing its effectiveness in proteintherapeutic analysis through enhanced sensitivity and dynamic range.
Scientists from the University of Zurich have discovered that prolonged immune system activity, lasting more than six months after acute SARS-CoV-2 infection, could be a contributing factor to long Covid.